ArticleCell death & disease2026

C/EBP alpha agonist ICCB280 overcomes doxorubicin resistance in osteosarcoma through mitochondrial dynamics-dependent GREM1-MAPK activation.

Yuchen Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.